Mural Health, a technology provider of clinical trial participant management solutions, has received awards for Innovation and Business Expansion in the 2025 Clinical Trials Arena Excellence Awards for its initiatives in enhancing participant experience and forming industry partnerships that have influenced patient-centricity and operational practices in clinical research.
The Clinical Trials Arena Excellence Awards honor the most significant achievements and innovations in the pharmaceutical clinical trials industry. Powered by GlobalData’s business intelligence, the Awards recognize the people and companies leading positive change and shaping the future of the industry.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Mural Health won the Innovation award for its participant-first approach that enhances the clinical trial experience through compassionate support and intuitive, streamlined technology. The company received the Business Expansion award for its successful strategic alliances, which have broadened the reach and impact of its solutions across the global clinical research industry.
Innovation in participant experience: Mural Health’s Patient Kindness Group
Mural Health received the Innovation award in the Participant Experience category for its distinctive and comprehensive approach to supporting clinical trial participants. At the core of this recognition is the Patient Kindness Group, launched in early 2024, which introduces a scalable, high-touch, 24/7 personalized support model. The initiative was developed in response to the realization that traditional participant management tools and reimbursement systems often overlook the emotional and practical challenges faced by trial participants and their families.
The Patient Kindness Group offers a single, dedicated point of contact for each participant, providing consistent and reliable support throughout the clinical trial journey. This dedicated contact conducts proactive and regular check-ins, remains available around the clock, and tailors communication methods to align with each participant’s preferences. The support extends beyond logistical assistance—such as travel coordination and payment management—to include empathetic, human-first care that addresses the unique challenges and needs of each participant.
A notable example of the Patient Kindness Group’s impact is seen in a global pediatric rare disease study supported by Mural Health. In this trial, families of terminally ill children traveled internationally to participate, requiring multilingual support, coverage across multiple time zones, and continuous availability. The Patient Kindness Group coordinated complex logistics and travel arrangements, provided a listening ear to families, and sent small gifts to participants to help brighten difficult days. This level of personalized care not only improved the participant experience but also led to high satisfaction among sponsors and site staff, resulting in requests for Mural Health to support additional studies.
The Patient Kindness Group is fully integrated into Mural Link, the company’s participant management platform that provides a suite of participant management tools, including payment and reimbursement support, tax management, in-app rideshare and travel coordination, secure communication, and real-time feedback analytics. Mural Health’s introduction of the industry’s first fee-free prepaid card and a wide range of global payment options—including PayPal, Venmo, Zelle, Revolut, and direct-to-account transfers—further reduces barriers to trial participation, particularly for low-income individuals who may otherwise be excluded due to financial constraints.
Mural Health’s participant-first approach has delivered measurable results, including a 60% reduction in participant drop-out rates, a 20% increase in enrollment speed, and a 97% engagement rate. The company also leverages participant feedback and analytics to proactively identify and address outlier experiences, ensuring continuous improvement in participant care. By prioritizing both the logistical and emotional well-being of participants, Mural Health has set a new standard for participant support in clinical trials.
“We built Patient Kindness because we knew clinical trial participants deserved more than transactional support — they deserve genuine compassion, empathy, and care. Receiving the Excellence in Innovation Award is a testament to the need for human-first experiences in clinical research, and we’re deeply honored by this recognition.”
– Sam Whitaker, Co-Founder & CEO of Mural Health
Business expansion through strategic alliances: Partnership with ICON
Mural Health was recognized in the Business Expansion category, specifically for Strategic Alliances, for its demonstrated ability to scale its solutions through impactful industry partnerships. The company’s strategic collaboration with ICON plc, a global leader in clinical research, marks a significant milestone in expanding the reach and adoption of the Mural Link platform.
Through this partnership, which was announced in February 2024, ICON will utilize Mural Link’s innovative functionality for clinical trial participant payments, tax management, travel and concierge support, site-participant communication tools, and novel reporting and analytics capabilities. Mural’s unique operating model and diverse payment options, including the industry’s only fee-free debit card option, will help ICON eliminate significant financial barriers that prevent trial participation. ICON’s customers will benefit from an increase in the total recruitable patient population, including large communities of historically underrepresented patient populations, and a reduction in participant-level operating challenges that drive patient-attrition.
The partnership enables ICON to deliver tangible benefits to both patients and sites, such as faster payments, reduced administrative burden, and improved participant engagement. By advancing participant financial neutrality and streamlining operational processes, the collaboration allows site staff to focus more on patient care rather than administrative tasks.
Under this alliance, Mural Link is now utilized to support many of the top pharmaceutical companies, as well as leading contract research organizations and health systems.
Mural Health’s ability to scale both its technology and high-touch services globally is evidenced by its support for trials in 48 countries and 120+ currencies, with local language capabilities. This global reach ensures that participants receive consistent support regardless of geography, and that sponsors and sites benefit from standardized, efficient processes.
The collaboration with ICON has accelerated Mural Health’s growth and expanded its influence within the clinical trials sector. By aligning with leading industry stakeholders and demonstrating real-world adoption of its solutions, Mural Health has reinforced its position as a key partner in enabling modern, patient-centric clinical trials.
“Our partnership with ICON underscores our shared commitment to participant financial neutrality, seamless trial logistics, and compassionate care. This award for Business Expansion reinforces that our combined approach of innovative technology and patient-centered care resonates deeply across the clinical research landscape.”
– Oshrat Goldberg, Chief Commercial Officer at Mural Health
Company Profile
Mural Health stands at the forefront as a patient-first technology innovator, devoted to simplifying clinical research engagement. The company targets areas ripe for significant enhancement, providing technological solutions designed to ease participation burdens for patients and caregivers alike, both locally and globally. With products like Mural Link, which streamlines participant payments, travel coordination, communication, and satisfaction measurement, Mural Health is dedicated to making the clinical trial experience easier.
For further information about Mural Health, visit https://www.muralhealth.com/.
Contact Details
Oshrat Goldberg – Chief Commercial Officer
E-mail: oshrat.goldberg@muralhealth.com
Links:
Website: www.muralhealth.com/
Signup to Mural Health’s Newsletter: https://www.muralhealth.com/newsletter/signup
